Astellas Pharma | 4503 - Selling And Administration Expenses

Stock Price
2,347.50
Daily Change
-14.00 -0.59%
Monthly
-3.18%
Yearly
58.61%
Q1 Forecast
2,263.03

Astellas Pharma reported JPY221.78B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Astellas Pharma JPY 221.78B 14.94B Dec/2025
Chugai Pharma JPY 36.93B 9.04B Dec/2025
Daiichi Sankyo JPY 228.23B 39.15B Dec/2025
Eisai JPY 111.72B 7.86B Dec/2025
Kyowa Hakko Kirin JPY 43.89B 5.17B Dec/2025
M3 JPY 26.49B 132M Dec/2025
Otsuka Holdings JPY 278.3B 24.08B Dec/2025
Shionogi JPY 35.48B 7.93B Dec/2025
Sumitomo Dainippon JPY 40.9B 5.25B Sep/2025
Takeda JPY 282.78B 29.23B Dec/2025
Terumo JPY 105.26B 7.38B Dec/2025